The Da Vinci surgical robot Xi system assisted laparoscopic pyeloureteroplasty uses the improved javelin side lying position, which can alleviate the unsafe factors of falling from the bed caused by the conventional posture, shorten the time of placing the posture5, prevent the possible pressure injuries and intraoperative complications caused by the conventional posture surgery, and the operation is more simple and convenient. The mechanical arm of the Da Vinci robot will not have the potential risk factors of crushing the head, face and trunk of the patient during the entire operation process, It is safe and reliable, making the whole process of positioning convenient and time-saving. It can not only improve the connection efficiency of each operation, but also ease the work intensity of nurses and reduce the incidence of robot secondary berths. Operator satisfaction. It is safe and reliable to achieve good results, improve the operation safety, effectively avoid intraoperative and postoperative complications, and ensure the operation safety of patients, which is worth promoting.
Full Title of Study: “Xu Pu, Director, Clinical Researcher”
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: January 9, 2022
To discuss the comparative study of different localization methods in robot-assisted laparoscopic epirenoplasty. From December 2021 to January 2022, the researchers selected 60 participants to undergo laparoscopic pyroplasty assisted by the Da Vinci Robotic Xi system. Depending on the order of the surgeries, the researchers randomly assigned them， the subjects into three groups: control group A, control group B and observation group C, each with 20 cases. In control group A, we adopted the conventional lateral position, control group B adopted the lumbar bridge cushion lateral position, and observation group C adopted the modified javelin lateral position, The operation time, secondary berth incidence, operation time, intraoperative blood loss and the incidence of intraoperative complications were compared among the three groups.
- Procedure: To explore the comparative study of different positioning methods in robot assisted laparoscopic pyeloplasty.
- The incidence of surgical positioning time and secondary berths, surgical time, intraoperative blood loss and intraoperative complications were compared among the three groups.
- Device: To discuss the comparative study of different position placement methods of renal pelvis ureteroplasty on the Da Vinci robotic Xi platform
- To discuss the comparative study of different position placement methods of renal pelvis ureteroplasty on the Da Vinci robotic Xi platform
Arms, Groups and Cohorts
- In control group A,
- In control group A, we adopted the conventional lateral position
- control group B
- control group B adopted the lumbar bridge cushion lateral position
- observation group C
- observation group C adopted the modified javelin lateral position
Clinical Trial Outcome Measures
- The da Vinci surgical robot Xi system assists laparoscopic pyeloneuroplasty with an absolute advantage in the modified javelin lateral recumbent position
- Time Frame: From December 2021 to January 2022
- The use of modified javelin side recumbent position during surgery can alleviate the unsafe factors of falling from the bed caused by conventional positioning, which is safe and reliable, and achieves good results
Participating in This Clinical Trial
Selection Criteria: 1. Clinical diagnosis of obstruction at the renal pelvis ureteral junction. 2. Must be able to fit the treatment done under the robot platform Exclusion Criteria:
1. Patients who can use balloon dilation to achieve the therapeutic purpose 2. Open surgery is required
Gender Eligibility: All
Minimum Age: 2 Months
Maximum Age: 5 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
- Lead Sponsor
- Guiyang Maternal and Child Health Care Hospital
- Provider of Information About this Clinical Study
- Overall Official(s)
- Jing P Liu, doctorat, Study Director, Guizhou Provincial People’s Hospital
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.